Get Our Top Trade Ideas Delivered Daily - 65% Off Now'
get this deal
España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now'
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Spruce Biosciences
SPRB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.464700
0.0002
0.04%
At Close: -
$0.464500
-0.0002
-0.04%
After Hours: Aug 30, 7:59 PM EDT
15 minutes delayed
Get Report
Comment
Spruce Biosciences (SPRB) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Spruce Biosciences (NASDAQ:SPRB) Stock
Spruce Biosciences Stock (NASDAQ: SPRB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, August 19, 2024
HC Wainwright & Co. Reiterates Neutral on Spr...
Benzinga Newsdesk
Tuesday, August 13, 2024
RBC Capital Reiterates Sector Perform on Spru...
Benzinga Newsdesk
Monday, August 12, 2024
Spruce Biosciences Q2 EPS $(0.22) Beats $(0.3...
Benzinga Newsdesk
Thursday, June 13, 2024
Oppenheimer Maintains Outperform on Spruce Bi...
Benzinga Newsdesk
Wednesday, June 05, 2024
HC Wainwright & Co. Reiterates Neutral on Spr...
Benzinga Newsdesk
Tuesday, June 04, 2024
Spruce Biosciences And HMNC Brain Health Coll...
Benzinga Newsdesk
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
Vandana Singh
Monday, June 03, 2024
Spruce Biosciences Presented Results From Pha...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Neutral on Spr...
Benzinga Newsdesk
Monday, May 13, 2024
Spruce Biosciences Q1 EPS $(0.28) Beats $(0.2...
Benzinga Newsdesk
Thursday, March 14, 2024
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
Vandana Singh
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
Avi Kapoor
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
Avi Kapoor
RBC Capital Downgrades Spruce Biosciences to ...
Benzinga Newsdesk
US Stocks Higher; Producer Prices Rise 0.6% In February
Avi Kapoor
HC Wainwright & Co. Downgrades Spruce Bioscie...
Benzinga Newsdesk
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
Vandana Singh
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Leerink Partners Downgrades Spruce Bioscience...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Guggenheim Downgrades Spruce Biosciences to N...
Benzinga Newsdesk
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Spruce Biosciences shares are trading lower a...
Benzinga Newsdesk
Wednesday, March 13, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Spruce Biosciences Shares Resume Trade
Benzinga Newsdesk
Trading Halt: Halt status updated at 4:35:00 ...
Benzinga Newsdesk
Spruce Biosciences Announces Resource Priorit...
Benzinga Newsdesk
Spruce Biosciences Reports FY23 EPS $(1.24) V...
Benzinga Newsdesk
Spruce Biosciences Announces CAHmelia-203 Stu...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:11 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, March 05, 2024
RBC Capital Reiterates Outperform on Spruce B...
Benzinga Newsdesk
Monday, February 26, 2024
RBC Capital Maintains Outperform on Spruce Bi...
Benzinga Newsdesk
Wednesday, February 21, 2024
Guggenheim Initiates Coverage On Spruce Biosc...
Benzinga Newsdesk
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, January 22, 2024
Spruce Biosciences Completes Enrollment In CA...
Benzinga Newsdesk
Friday, January 05, 2024
Spruce Biosciences Reports Baseline Character...
Benzinga Newsdesk
Thursday, January 04, 2024
Spruce Biosciences Provides Clinical Program ...
Benzinga Newsdesk
Wednesday, November 29, 2023
Spruce Biosciences Chief Executive Officer Awarded $177K Worth of Stock Options
Benzinga Insights
Monday, November 20, 2023
What 4 Analyst Ratings Have To Say About Spruce Biosciences
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Spruce ...
Benzinga Newsdesk
Monday, November 13, 2023
Spruce Biosciences Q3 EPS $(0.30) Beats $(0.3...
Benzinga Newsdesk
Friday, October 20, 2023
Top 4 Health Care Stocks That May Rocket Higher This Month
Lisa Levin
Wednesday, October 18, 2023
Spruce Biosciences Completes Target Enrollmen...
Benzinga Newsdesk
Wednesday, September 13, 2023
RBC Capital Reiterates Outperform on Spruce B...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Spruce ...
Benzinga Newsdesk
Friday, September 08, 2023
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
Benzinga Insights
Analyst Ratings for Spruce Biosciences
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch